BioCentury
ARTICLE | Financial News

The Column Group financial update

April 21, 2014 7:00 AM UTC

Biotech VC firm The Column Group has raised $175.9 million of a planned $250 million for its second fund, according to an SEC filing. The firm could not be reached for details in time for publication....